Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
Florida Cancer Specialists, Sarasota, Florida Dana Farber Cancer Institute, Boston, Massachusetts START Midwest, Grand Rapids, Michigan Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada UH Seidman Cancer Center, Cleveland, Ohio Oregon Health and Science University, Portland, Oregon Sarah Cannon Research Institute, Nashville, Tennessee MD Anderson Cancer Center, Houston, Texas NEXT Oncology, San Antonio, Texas START Mountain, West Valley City, Utah